The CNPV pilot program approved its first drug, an amoxicillin-clavulanate potassium antibiotic, in two months, enhancing domestic manufacturing and national security. Augmentin XR, combining ...
In an unusual twist in its history, VGK is outperforming VOO and SPY by 79%, due largely to fears about the US markets and ...
Asian News International on MSN
Dr. Hafsa Ahmad, Dr. Anita Aggarwal on attending 7th CII Pharma & Life Sciences Summit 2025
Dr. Hafsa Ahmad, Dr. Anita Aggarwal shared experience of attending 7th CII Pharma & Life Sciences Summit 2025. The summit ...
In an update on its social media account, Rocket Lab Corp. (NASDAQ:RKLB) said that it is set to launch a new Electron mission ...
Bangkok Post on MSN
Pact aims to rev up pharma patent use
The collaboration aims to enhance health offerings to better serve an ageing society and address emerging diseases.Auramon Supthaweethum, director-general of the DIP, said the two organisations are ...
Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...
The framework has had a lukewarm reaction, with trade association EFPIA saying the policies are “not strong enough”.
Equity Insider News Commentary – Major pharmaceutical companies are cutting drug discovery timelines by 30% or more through ...
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, ...
Sam Glassenberg, EVP of Relevate Health Games, launched this session at the AI Deciphered conference by pointing out how wholeheartedly the video game industry has embraced generative AI. Indeed, the ...
ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback